Links
Avandia
FDA - Safety Review of Avandia
FDA Issues Safety Alert on Avandia
FDA - Ongoing Review of Cardiovascular Safety
Reglan
FDA - REGLAN Safety Labeling Changes
Yaz
2008 Warning Letter sent to the makers of YAZ
FDA - YAZ Safety Label Changes
2009 Warning Letter sent to the makers of YAZ
Paxil
FDA - Public Health Advisory for Paxil
National Institute of Mental Health Paper on antidepressant effectiveness
National Institute of Mental Health Paper on antidepressant medication for children and adolescents
SSRI (Selective Seratone Reuptake Inhibitors)
FDA - SSRI - Change in Medication Guidelines
Increased Risk of Neonatal Persistent Pulmonary Hypertension
ACNP Comments On SSRI Use In Adolescents
NIMH Paper on Antidepressant Medications for Children and Adolescents
FOSAMAX - specifically about Femur Fractures
FDA - FOSAMAX Safety Label Changes
Novartis Pharmaceutical Corp Study
FDA - Ongoing Safety Review - FOSAMAX and Femur Fractures